MAPK8 and neuroblastoma: SB203580, JNK1/2 inhibitor, exhibited no effect on the RA-treated NB cells, but curcumin, which also interferes with the JNK pathway, blocks RA-mediated NB differentiation without causing cellular proliferation arrest [41,44].